Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Scholar Rock

Scholar Rock
2012 FOUNDED
PUBLIC STATUS
61-70 EMPLOYEES
SRRK STOCK SYMBOL
$21.21 SHARE PRICE (As of Tuesday Closing)
Description

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The company's lead product candidate is SRK-015 which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 620 Memorial Drive
  • 2nd Floor
  • Cambridge, MA 02139
  • United States

+1 (857) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Scholar Rock’s full profile, request a free trial.

Scholar Rock Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$13.09 - $30.00 $556M $20.54 -$2.68 116K 26.2M

Scholar Rock Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 317,477 654,533
Revenue 3,106 0 0 379
EBITDA (52,274) (49,941) (24,370) (15,613)
Net Income (51,190) (49,326) (24,995) (16,207)
Total Assets 170,982 181,336 61,637 32,782
Total Debt 270 462 1,039 1,670
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Scholar Rock Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Scholar Rock‘s full profile, request access.

Request full access to PitchBook

Scholar Rock Competitors (45)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NGM Biopharmaceuticals Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
0000 000000 Formerly VC-backed San Diego, CA 00 00000 000000000 00000
0000 00000000000 Formerly VC-backed Redwood City, CA 00 00000 000000&0 00000
0000 000000000000 Formerly VC-backed Cambridge, MA 00 00000 000000000 00000
0000000 00000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
To view this company’s complete list of competitors, request access »

Scholar Rock Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Scholar Rock‘s full profile, request access.

Request full access to PitchBook

Scholar Rock Executive Team (11)

Name Title Board
Seat
Contact
Info
Nagesh Mahanthappa Ph.D Chief Executive Officer, Board Member & President
Elan Ezickson JD Chief Operating Officer & Head, Corporate Development
Alan Buckler Ph.D Chief Scientific Officer
Leonard Zon MD Scientific Advisor & Co-Founder
Katherine Turner Ph.D Senior Vice President, Research

1 Former Executive

You’re viewing 5 of 11 executives. Get the full list »

Scholar Rock Board Members (9)

Name Representing Role Since Contact
Info
Amir Nashat Ph.D Polaris Partners Board Member 000 0000
David Hallal Self Chairman 000 0000
Jeffrey Flier MD Scholar Rock Board Member 000 0000
Kristina Burow ARCH Venture Partners Board Member 000 0000
Leonard Zon MD Scholar Rock Scientific Advisor & Co-Founder 000 0000

1 Former Board Member

You’re viewing 5 of 9 board members. Get the full list »